drugset / Trial / NCT03062501
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will investigate the safety, tolerability and potential for the use of up to three daily doses of 30-40 mg/kg HU (daily) upon hospitalization for painful vaso-occlusive crises .
Timeline
- Start
- 2016-11
- Primary completion
- 2017-04
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | 30 mg/kg | — |
| Subject | Hydroxyurea | Other / unclassified | 40 mg/kg | — |